The drug development process:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Dekker
1996
|
| Schriftenreihe: | Drugs and the pharmaceutical sciences
76 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XVIII, 447 S. |
| ISBN: | 0824797272 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011072463 | ||
| 003 | DE-604 | ||
| 005 | 20130613 | ||
| 007 | t | ||
| 008 | 961121s1996 |||| 00||| eng d | ||
| 020 | |a 0824797272 |9 0-8247-9727-2 | ||
| 035 | |a (OCoLC)34912681 | ||
| 035 | |a (DE-599)BVBBV011072463 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-188 |a DE-578 | ||
| 050 | 0 | |a RM301.25 | |
| 082 | 0 | |a 615/.19 |2 20 | |
| 084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
| 245 | 1 | 0 | |a The drug development process |c ed. by Peter G. Welling ... |
| 264 | 1 | |a New York [u.a.] |b Dekker |c 1996 | |
| 300 | |a XVIII, 447 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Drugs and the pharmaceutical sciences |v 76 | |
| 650 | 4 | |a Drugs - Research | |
| 650 | 7 | |a Farmacotecnica industrial |2 larpcal | |
| 650 | 4 | |a Industrie pharmaceutique | |
| 650 | 4 | |a Médicaments - Recherche | |
| 650 | 7 | |a Quimica farmaceutica |2 larpcal | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Drug Evaluation | |
| 650 | 4 | |a Drug Evaluation, Preclinical | |
| 650 | 4 | |a Drug Industry |x organization & administration | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Welling, Peter G. |e Sonstige |4 oth | |
| 830 | 0 | |a Drugs and the pharmaceutical sciences |v 76 |w (DE-604)BV000002008 |9 76 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007416802&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007416802 | ||
Datensatz im Suchindex
| _version_ | 1804125562733592576 |
|---|---|
| adam_text | 12 HIE DRUG DEVELOPMENT PROCESS EDITED BY PETER G. WELLING PARKE-DAVIS
PHARMACEUTICAL RESEARCH ANN ARBOR, MICHIGAN LOUIS LASAGNA TUFTS CENTER
FOR THE STUDY OF DRUG DEVELOPMENT BOSTON, MASSACHUSETTS UMESH V. BANAKAR
ST. LOUIS COLLEGE OF PHARMACY ST. LOUIS, MISSOURI MARCEL DEKKER, INC.
NEW YORK* BASEL * HONG KONG CONTENTS FOREWORD MARCUS M. REIDENBERG HI
PREFACE VII INTRODUCTION: WHITHER DRUG DEVELOPMENT? IX CONTRIBUTORS XVII
PART I: CHANGING PERSPECTIVES IN DRUG DEVELOPMENT 1. THE EVOLVING DRUG
DISCOVERY AND DEVELOPMENT PROCESS 1 JOHN C. SOMBERG 2. REDEFINING
COMPETITION IN THE PHARMACEUTICAL INDUSTRY: A TIME FOR CHOICE 39 JOHN
THOMPSON AND JAN GUGLIOTTI PART II: PROCESS CHALLENGES IN DRUG
DEVELOPMENT 3. THE IMPACT OF LIABILITY AND COST CONTAINMENT ON THE DRUG
DEVELOPMENT PROCESS 45 MARTHA M. RUMORE 4. MANAGING THE OVERALL
PORTFOLIO FOR SUCCESSFUL DISCOVERY AND DEVELOPMENT 79 REBECCA J.
ANDERSON XIII XIV CONTENTS PART III: PHARMACEUTICAL AND FORMULATION
FACTORS 5. PHARMACEUTICAL ISSUES IN DRUG DEVELOPMENT 117 UMESH V.
BANAKAR AND MICHAEL C. MAKOID 6. NOVEL DRUG DELIVERY SYSTEMS 169 BRET
BERNER AND AGIS KYDONIEUS PART IV: DRUG DESIGN, PHARMACOKINETICS, AND
TOXICOLOGY 7. COMPUTER-AIDED DRUG DESIGN 203 TERRY R. STOUCH 8. NEW
APPROACHES TO NONCLINICAL BIODISPOSITION STUDIES 219 D. BRUCE CAMPBELL
9. CHANGES IN PHARMACOKINETICS AND DRUG METABOLISM RESPONSIBILITY IN
DRUG DISCOVERY AND DEVELOPMENT 261 PETER G. WELLING PART V: CHEMOTHERAPY
10. ANTICANCER DRUG DEVELOPMENT 281 JIM CASSIDY PART VI: CLINICAL
STUDIES AND THE USE OF CLINICAL RESEARCH ORGANIZATIONS 11. CLINICAL
PHARMACOLOGY IN DRUG DEVELOPMENT: A VIEW TO FUTURE EFFECTIVENESS 295 /.
ROBERT POWELL, ALAN BYE, AND PAUL D. RUBIN 12. CONTRACTING CROS INTO
YOUR ORGANIZATION: NEW STRATEGIES FOR NEW CHALLENGES 317 GARY D.
LIGHTFOOT AND JOHN R. VOGEL 13. THE ROLE OF CLINICAL RESEARCH
ORGANIZATIONS IN DRUG DEVELOPMENT 337 ALBERT J. SIEMENS AND JAMES E.
HIGGINS PART VII: EUROPEAN AND JAPANESE APPROACHES 14. UNDERSTANDING
DRUG DEVELOPMENT AND REGISTRATION IN JAPAN 353 W. J. C. CURRIE CONTENTS
XV 15. INCREASING THE EFFECTIVENESS OF CLINICAL PATHOLOGY TESTING AND
ITS VALUE TO DRUG DEVELOPMENT IN EUROPE 377 DAI DAVIES AND KAROLYN
JACKSON 16. NEW MARKETING AUTHORIZATION PROCEDURES IN THE EUROPEAN UNION
AND THE IMPACT ON REGULATORY STRATEGY 421 VAILA M. MARSHALL INDEX 443
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV011072463 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.25 |
| callnumber-search | RM301.25 |
| callnumber-sort | RM 3301.25 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | VS 5350 |
| ctrlnum | (OCoLC)34912681 (DE-599)BVBBV011072463 |
| dewey-full | 615/.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.19 |
| dewey-search | 615/.19 |
| dewey-sort | 3615 219 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01881nam a2200505 cb4500</leader><controlfield tag="001">BV011072463</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130613 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">961121s1996 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824797272</subfield><subfield code="9">0-8247-9727-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)34912681</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011072463</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.25</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The drug development process</subfield><subfield code="c">ed. by Peter G. Welling ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 447 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">76</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs - Research</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmacotecnica industrial</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Recherche</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Quimica farmaceutica</subfield><subfield code="2">larpcal</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="x">organization & administration</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Welling, Peter G.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drugs and the pharmaceutical sciences</subfield><subfield code="v">76</subfield><subfield code="w">(DE-604)BV000002008</subfield><subfield code="9">76</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007416802&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007416802</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV011072463 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T18:03:32Z |
| institution | BVB |
| isbn | 0824797272 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007416802 |
| oclc_num | 34912681 |
| open_access_boolean | |
| owner | DE-12 DE-188 DE-578 |
| owner_facet | DE-12 DE-188 DE-578 |
| physical | XVIII, 447 S. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Dekker |
| record_format | marc |
| series | Drugs and the pharmaceutical sciences |
| series2 | Drugs and the pharmaceutical sciences |
| spelling | The drug development process ed. by Peter G. Welling ... New York [u.a.] Dekker 1996 XVIII, 447 S. txt rdacontent n rdamedia nc rdacarrier Drugs and the pharmaceutical sciences 76 Drugs - Research Farmacotecnica industrial larpcal Industrie pharmaceutique Médicaments - Recherche Quimica farmaceutica larpcal Drug Design Drug Evaluation Drug Evaluation, Preclinical Drug Industry organization & administration Drug development Pharmaceutical industry Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Welling, Peter G. Sonstige oth Drugs and the pharmaceutical sciences 76 (DE-604)BV000002008 76 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007416802&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | The drug development process Drugs and the pharmaceutical sciences Drugs - Research Farmacotecnica industrial larpcal Industrie pharmaceutique Médicaments - Recherche Quimica farmaceutica larpcal Drug Design Drug Evaluation Drug Evaluation, Preclinical Drug Industry organization & administration Drug development Pharmaceutical industry Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| subject_GND | (DE-588)4143176-5 (DE-588)4143413-4 |
| title | The drug development process |
| title_auth | The drug development process |
| title_exact_search | The drug development process |
| title_full | The drug development process ed. by Peter G. Welling ... |
| title_fullStr | The drug development process ed. by Peter G. Welling ... |
| title_full_unstemmed | The drug development process ed. by Peter G. Welling ... |
| title_short | The drug development process |
| title_sort | the drug development process |
| topic | Drugs - Research Farmacotecnica industrial larpcal Industrie pharmaceutique Médicaments - Recherche Quimica farmaceutica larpcal Drug Design Drug Evaluation Drug Evaluation, Preclinical Drug Industry organization & administration Drug development Pharmaceutical industry Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| topic_facet | Drugs - Research Farmacotecnica industrial Industrie pharmaceutique Médicaments - Recherche Quimica farmaceutica Drug Design Drug Evaluation Drug Evaluation, Preclinical Drug Industry organization & administration Drug development Pharmaceutical industry Arzneimittelentwicklung Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007416802&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000002008 |
| work_keys_str_mv | AT wellingpeterg thedrugdevelopmentprocess |